Deep sequence models for blood glucose forecasting consistently fail to leverage clinically informative drivers--insulin, meals, and activity--despite well-understood physiological mechanisms. We term this Driver-Blindness and formalize it via Δdrivers, the performance gain of multivariate models over matched univariate baselines. Across the literature, Δdrivers is typically near zero. We attribute this to three interacting factors: architectural biases favoring autocorrelation (C1), data fidelity gaps that render drivers noisy and confounded (C2), and physiological heterogeneity that undermines population-level models (C3). We synthesize strategies that partially mitigate Driver-Blindness--including physiological feature encoders, causal regularization, and personalization--and recommend that future work routinely report Δdrivers to prevent driver-blind models from being considered state-of-the-art.